Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513513
Status:
TERMINATED
Last Update Posted:
2010-04-26
First Post:
2007-08-06
Brief Title:
TMC114-C227 A Study to Evaluate the Effectiveness and Safety of TMC114 Darunavir With a Low Dose of Ritonavir as Monotherapy no Other Anti-HIV Drugs Will be Given in Patients Who Have Never Been Treated With Antiretrovirals Anti-HIV Drugs Previously
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-06
First Submit QC Date:
August 6 2007
Study First Post Date:
2007-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-22
Last Update Post Date:
2010-04-26
Last Update Post Date Type:
ESTIMATED